Isotopia Molecular Imaging ⚠ Under review

About

Headcount over time

Offices

Q&A

What is Isotopia Molecular Imaging's primary business?

Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes diagnostic and therapeutic radioactive isotopes and advanced PET and SPECT radiotracers.

What is Isotopia Molecular Imaging's flagship product?

Isotopia Molecular Imaging's flagship product is the radioisotope Lutetium-177 (both C.A and N.C.A), which is used in treating various late-stage cancers, including metastatic prostate cancer and neuroendocrine tumors.

When was Isotopia Molecular Imaging founded?

Isotopia Molecular Imaging was founded in February 2007.

How much funding has Isotopia Molecular Imaging raised in total?

Isotopia Molecular Imaging has raised a total of $3,750,000.

When was Isotopia Molecular Imaging's last funding round and who were the lead investors?

Isotopia Molecular Imaging's last funding round was in July 2007, with Metrontario as the lead investor.

How many employees does Isotopia Molecular Imaging have?

Isotopia Molecular Imaging has 51-200 employees.

Where is Isotopia Molecular Imaging's headquarters located?

Isotopia Molecular Imaging's headquarters is located in Petah Tikva, Israel.

Who is the Co-founder and CEO of Isotopia Molecular Imaging?

Dr. Eli Shalom is the Co-founder and CEO of Isotopia Molecular Imaging.

Team · 9

Eli Shalom

Founder · Co-founder & CEO

Dan Amit

Head of Professional Services

Sil Weisemberg

Marketing Communications Specialist

Omer Rubinshtein

Nuclear pharmacist in charge & QA Manager

Zahe Kore

Operations Manager

Orel Dadush

Operations Manager

Yossi Shohet

Plant engineer & Cyclotron PM

Moriya Pintz

QC Lab Manager

Tzachi Levi

Site Manager

Sectors & technology

Highlights

Tags